CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO".
from The Medical News http://ift.tt/13AiQ6z
from The Medical News http://ift.tt/13AiQ6z
No comments:
Post a Comment